Living healthily to 120: Implications for entrepreneurship

Marco van Gelderen

Journal of Business Venturing, 2025, vol. 40, issue 4

Abstract: Research on how to slow, halt, and reverse aging processes is making progress. Pharmaceutical, big-tech, and venture capital companies and their owners are making considerable investments in potential (epi)genetic, molecular, cellular, and organ-based interventions and therapies. This essay considers implications for entrepreneurship in the case that such interventions would eventually result in a doubling of the human healthspan. A vastly extended middle age would imply potential changes in opportunities, the future time perspective of entrepreneurs, the pace of time as experienced by entrepreneurs, and the relationship between age and entrepreneurial success. The essay also outlines a range of wider considerations. The final section ties the essay together by discussing how entrepreneurship scholarship can help move the longevity domain forward.

Keywords: Entrepreneurship; Aging; Longevity; Future; Healthspan (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0883902625000400
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:jbvent:v:40:y:2025:i:4:s0883902625000400

DOI: 10.1016/j.jbusvent.2025.106512

Access Statistics for this article

Journal of Business Venturing is currently edited by S. Venkataraman

More articles in Journal of Business Venturing from Elsevier
Bibliographic data for series maintained by Catherine Liu ().